Features of the clinical course of a new coronavirus infection in children


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background. Commonly, a new coronavirus infection in the pediatric population is characterized by an asymptomatic or oligosymptomatic course, in contrast to adults. The most common symptoms of COVID-19 in children include fever, catarrhal signs, intoxication of varying severity. Objective. Analysis of the clinical course of a new coronavirus infection in children in outpatient settings. Methods. An analysis of 78 case histories of children with COVID-19 who were treated in the Penza City Children’s Polyclinic, Children’s Polyclinic № 3 from September 2020 to February 2021 was performed. Results. It was revealed that the mean age of patients was 8.8 years. There were 52 boys (66.7%), 26 girls (33.3%). Asymptomatic course was diagnosed in 10 (12.8%) children, mild severity - in 52 (66.7%), moderate severity - in 16 (20.5%) children. The mean duration of illness was 18.5 days. In children with moderate COVID-19 severity, broncho-obstructive syndrome with a protracted course dominated in the clinical picture. Conclusion. Coronavirus infection in children can occur with broncho-obstructive syndrome. The first episode of bronchial obstruction may be the debut of bronchial asthma, which requires dynamic monitoring by a pediatrician, consultation with an allergist-immunologist, and a comprehensive examination after a COVID-19 infection. Evaluation of the features of the course of the disease, as well as monitoring its long-term consequences, remains relevant today.

全文:

受限制的访问

作者简介

Alina Turovskaya

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education; City Children's Polyclinic

Email: alinaziboreva@yandex.ru
Postgraduate student at the Department of Clinical Immunology and Allergology; Pediatrician Penza, Russia

E. Kostina

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education

Penza, Russia

E. Orlova

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education

Penza, Russia

E. Trushina

Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education

Penza, Russia

G. Grishanovich

City Children's Polyclinic

Penza, Russia

O. Sidorova

City Children's Polyclinic

Penza, Russia

E. Avdoshina

City Children's Polyclinic

Penza, Russia

参考

  1. Dong Y., Mo X., Hu Y., et al. Epidemiological characteristics of 2143 pediatric patients with 2019 Coronavis Disease in China. Pediatrics. 2020;145(6). doi: 10.1542/peds.2020-0702.
  2. Намазова-Баранова Л.С. Коронавирусная инфекция (Covid-19) у детей (состояние на апрель 2020). Педиатрическая фармакология. 2020;17(2):85-94. doi: 10.15690/pf.v17i2.2094.
  3. Snape M.D., Viner R.M. COVID-19 in children and young people. Science. 2020;370(6514):286-88. doi: 10.1126/science.abd6165
  4. URL: https://coronavirusonline.com.ua/countries/
  5. URL: https://www.rospotrebnadzor.ru/about/info/predpr/news_predpr.php?ELEMENT_ID=15344&sphrase_id=3165929
  6. URL: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
  7. Временные методические рекомендации: особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей. Версия 2 (03.07.2020) (Электронный ресурс). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf
  8. Alsohimea E., Temsaha M-H., Al-Nemri A.M., et al. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. J Infect Public Health. 2020;13:1791-96. doi: 10.1016/j.jiph.2020.10.008.
  9. Mehta N.S., Mytton O., Mullins E., et al. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review. Lancet Inrect Dis. 2020;9(71):2469-79. doi: 10.1093/cid/ciaa556.
  10. Wu Q., Xing Y., Shi L., et al. Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics. 2020;146(1):1-9. doi: 10.1542/peds.2020-0961.
  11. Tagarro A., Epalza C., Santos M., et al. Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. 2020;174(10):1009. doi: 10.1001/jamapediatrics.2020.1528.
  12. Miri S.M., Noorbakhsh E., Mohebbi S.R., Ghaemi A. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues. J Med Virol. 2020;92(11):1-3. doi: 10.1002/jmv.26069
  13. Заплатников А.Л., Свинцицкая В.И. COVID-19 и дети. Русский медицинский журнал. 2020;6:20-2.
  14. Suratannon N., Dik W.A., Chatchatee P., Hagen PM. COVID-19 in children: Heterogeneity within the disease and hypothetical pathogenesis. Asian Pac J Allergy Immunol. 2020;38:170-77. doi: 10.12932/AP-170720-0920.
  15. Bunyavanich S., Do A., Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020;323(23):2427-29. doi: 10.1001/jama.2020.8707.
  16. Moeller A., Thanikkel L., Duijts L., et al. COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres. ERJ Open Research. 2020;6(4):00409-2020. doi: 10.1183/23120541.00409-2020.
  17. Cardona-Hernandez R., Cherubini V., Iafusco D., et al. Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr Diabetes. 2021;22:202-6. doi: 10.1111/pedi.13158.
  18. Александрович Ю.С., Байбарина Е.Н., Баранов А.А. и др. Ведение детей с заболеванием, вызванным новой коронавирусной инфекцией (SARS-CoV-2). Педиатрическая фармакология. 2020;17(2):103-18. doi: 10.15690/pf.v17i2.2096.
  19. Ramakrishnan S., Nicolau D.V., Langford B., Mahdi M. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763-72. doi: 10.1016/S2213-2600(21)00160-0.
  20. Castro-Rodriguez J.A. Asthma and COVID-19 in children: A systematic review and call for data. Pediatr Pulmonol. 2020;55(9):2412-18. doi: 10.1002/ppul.24909.
  21. Arden K.E., Chang A.B., Lambert S.B., et al. Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol. 2010;82:1458-61. doi: 10.1002/jmv.21819.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##